antiretroviral medicines
318 articles related to "antiretroviral medicines"
-
Gilead Licenses HIV medicines to Patent Pool, But Several Countries Left Out
The drive behind the Patent Pool was to find a solution to the lack of access to newer HIV/AIDS medicines and to combination treatments for people living in developing countries. Now that the first...
Web article – Last updated 20 July 2011
msfaccess.org/content/gilead-licenses-hiv-medicines-patent-pool-several-countries-left-out -
Untangling the Web of Antiretroviral Price Reductions: 14th Edition
The latest edition of Untangling the Web of Antiretroviral Price Reductions (UTW) released at the IAS 2011 in Rome demonstrates a growing and deadly divide in antiretroviral (ARV) prices offered to...
Report – Last updated 18 July 2011
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-14th-edition -
Provisions in U.S. Domestic Health Care Legislation Could Limit Access to Vaccines and New Class of Drugs
The international medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a little-discussed provision in the proposed U.S. domestic health care legislation...
Web article – Last updated 12 January 2010
msfaccess.org/content/provisions-us-domestic-health-care-legislation-could-limit-access-vaccines-and-new-class -
New Report highlights India's role as "lifeline" for patients in developing countries
AIDS treatment has seen progress in recent years, with about four million people starting treatment between 2003 and 2008, due largely to India's ability to produce low-cost quality medicines. Indian-produced...
Web article – Last updated 20 September 2010
msfaccess.org/content/new-report-highlights-indias-role-lifeline-patients-developing-countries-0 -
Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries
Each year, MSF publishes a survey of the latest prices for antiretroviral medicines to treat people living with HIV/AIDS in developing countries. It started out as a way of offering a practical guide...
Web article – Last updated 08 August 2011
msfaccess.org/content/caught-middle-%E2%80%93-hiv-medicines-pricing-sky-high-%E2%80%98middle-income%E2%80%99-countries -
Make It Happen Campaign: Update 6
Over 300,000 messages of support help realise creation of UNITAID’s patent pool Great news: thanks in no small part to the participation of thousands of individuals in the Make It Happen Campaign,...
Web article – Last updated 16 December 2009
msfaccess.org/content/make-it-happen-campaign-update-6 -
Make It Happen Campaign: Update 4
The ‘Make It Happen’ campaign is calling on pharmaceutical companies to put their HIV drug patents in the UNITAID patent pool. The pool could mean that people in developing countries can...
Web article – Last updated 30 November 2009
msfaccess.org/content/make-it-happen-campaign-update-4 -
Make It Happen Campaign: Update 3
Over 110,000 emails sent to the drug companies six weeks after our launch. We’re spreading more widely now – the latest boost online came from people signing up in Brazil and we also...
Web article – Last updated 13 November 2009
msfaccess.org/content/make-it-happen-campaign-update-3 -
Make It Happen Campaign Launches
Welcome to our campaign update where we let you know what’s been happening with the Make It Happen campaign. We’ve launched! Wednesday 7th October: Just over a week since the launch...
Web article – Last updated 07 October 2009
msfaccess.org/content/make-it-happen-campaign-launches -
MSF responds to World Health Organization’s new HIV treatment guidelines
The World Health Organization (WHO) has issued new recommendations for the prevention and treatment of HIV/AIDS in developing countries, in line with the medical evidence and best practices. Below we...
Web article – Last updated 04 December 2009
msfaccess.org/content/msf-responds-world-health-organization%E2%80%99s-new-hiv-treatment-guidelines
↑ To top


